OTCMKTS:CSLLYCommonwealth Bank of Australia Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Commonwealth Bank of Australia Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $95.66 -0.44 (-0.46 %) (As of 05/29/2020 08:57 AM ET) Add Compare Share Today's Range$95.00Now: $95.66▼$96.2050-Day Range$95.86MA: $99.78▼$104.9152-Week Range$69.98Now: $95.66▼$114.40Volume34,027 shsAverage Volume42,310 shsMarket Capitalization$86.86 billionP/E Ratio45.12Dividend Yield0.86%Beta0.67 ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendHeadlinesSocial Media CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. It also operates approximately 140 plasma collection centers. In addition, this segment conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and developsinfluenza vaccines. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Commonwealth Bank of Australia. Previous Next 2.0 Community Rank Outperform VotesCommonwealth Bank of Australia has received 31 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCommonwealth Bank of Australia has received 47 “underperform” votes. (Add your “underperform” vote.)Community SentimentCommonwealth Bank of Australia has received 60.26% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Commonwealth Bank of Australia and other stocks. Vote “Outperform” if you believe CSLLY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CSLLY will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 3.3 Dividend Strength Dividend LeadershipCommonwealth Bank of Australia is a leading dividend payer. It pays a dividend yield of 0.86%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthCommonwealth Bank of Australia does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Commonwealth Bank of Australia is 38.68 %. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Commonwealth Bank of Australia will have a dividend payout ratio of 32.93 % next year. This indicates that Commonwealth Bank of Australia will be able to sustain or increase its dividend. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Commonwealth Bank of Australia insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.18% of the stock of Commonwealth Bank of Australia is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Commonwealth Bank of Australia are expected to grow by 4.18% in the coming year, from $2.39 to $2.49 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Commonwealth Bank of Australia is 45.12, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 14.81.Price to Earnings Ratio vs. SectorThe P/E ratio of Commonwealth Bank of Australia is 45.12, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.22.Price to Book Value per Share RatioCommonwealth Bank of Australia has a P/B Ratio of 16.49. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 3.3Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.19 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CSLLY Previous Symbol CUSIPN/A CIKN/A Webwww.csl.com.au Phone61-3-9389-1911Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E Ratio45.12 Forward P/E Ratio40.02 P/E GrowthN/A Sales & Book Value Annual Sales$8.54 billion Price / Sales10.17 Cash Flow$2.52 per share Price / Cash Flow37.95 Book Value$5.80 per share Price / Book16.49Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees25,000 Outstanding Shares908,100,000Market Cap$86.86 billion Next Earnings DateN/A OptionableNot Optionable OTC:CSLLY Rates by TradingView Receive CSLLY News and Ratings via Email Sign-up to receive the latest news and ratings for CSLLY and its competitors with MarketBeat's FREE daily newsletter. Commonwealth Bank of Australia (OTCMKTS:CSLLY) Frequently Asked Questions How has Commonwealth Bank of Australia's stock been impacted by COVID-19 (Coronavirus)? Commonwealth Bank of Australia's stock was trading at $101.09 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CSLLY stock has decreased by 5.4% and is now trading at $95.6550. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Commonwealth Bank of Australia? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Commonwealth Bank of Australia in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Commonwealth Bank of Australia. How often does Commonwealth Bank of Australia pay dividends? What is the dividend yield for Commonwealth Bank of Australia? Commonwealth Bank of Australia declared a Semi-Annual dividend on Thursday, August 15th. Stockholders of record on Tuesday, September 10th will be paid a dividend of $0.45 per share on Monday, October 21st. The ex-dividend date of this dividend is Monday, September 9th. View Commonwealth Bank of Australia's dividend history. Has Commonwealth Bank of Australia been receiving favorable news coverage? Press coverage about CSLLY stock has been trending extremely negative on Friday, according to InfoTrie Sentiment. The research firm rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Commonwealth Bank of Australia earned a daily sentiment score of -4.8 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutCommonwealth Bank of Australia. Who are some of Commonwealth Bank of Australia's key competitors? Some companies that are related to Commonwealth Bank of Australia include Roche Holdings AG Basel (RHHBY), Pfizer (PFE), Novartis (NVS), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Novo Nordisk A/S (NVO), Eli Lilly And Co (LLY), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), AbbVie (ABBV), Sanofi (SNY), GlaxoSmithKline (GSK), Celgene (CELG), Vertex Pharmaceuticals (VRTX) and Zoetis (ZTS). View all competitors. Who are Commonwealth Bank of Australia's key executives? Commonwealth Bank of Australia's management team includes the following people: Mr. Paul R. Perreault, MD, CEO & Exec. Director (Age 62)Mr. David Mark Lamont ACA, BCom, Chief Financial Officer (Age 53)Dr. Robert Andrew Cuthbertson, Chief Scientific Officer & Director of R&D and Director (Age 64)Mr. Gregory Boss BS(Hons), J.D., Exec. VP of Legal & Group Gen. Counsel (Age 58)Ms. Elizabeth Walker, Exec. VP & Chief HR Officer (Age 49) What is Commonwealth Bank of Australia's stock symbol? Commonwealth Bank of Australia trades on the OTCMKTS under the ticker symbol "CSLLY." How do I buy shares of Commonwealth Bank of Australia? Shares of CSLLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Commonwealth Bank of Australia's stock price today? One share of CSLLY stock can currently be purchased for approximately $95.66. How big of a company is Commonwealth Bank of Australia? Commonwealth Bank of Australia has a market capitalization of $86.86 billion and generates $8.54 billion in revenue each year. The company earns $1.92 billion in net income (profit) each year or $2.12 on an earnings per share basis. Commonwealth Bank of Australia employs 25,000 workers across the globe. What is Commonwealth Bank of Australia's official website? The official website for Commonwealth Bank of Australia is www.csl.com.au. How can I contact Commonwealth Bank of Australia? Commonwealth Bank of Australia's mailing address is 45 Poplar Road, Parkville C3, 3052. The company can be reached via phone at 61-3-9389-1911 or via email at [email protected] This page was last updated on 5/29/2020 by MarketBeat.com Staff
